产品服务
Product Service
Medical Beauty
Section
Sculpture aesthetics of xiangpeiyuzhuo
立秀e-PTFE隆鼻材料
膨体聚四氟乙烯(e-PTFE)由Gore于1969年首次合成,随后这种材料被引入心血管外科、普通外科、泌尿外科、胎儿外科、整形外科等,越来越广泛地应用于临床。
立秀隆鼻材主要采用加强型和成型膨体,植入后自然逼真,血管组织长入后,膨体材料。迅速与人体组织融为一体,不反光,不活动,重量轻,无下坠感。e-PTFE临床应用近30年,未见任何致癌报道。
Expanded polytetrafluoroethylene (e-PTFE) was first synthesized by Gore in 1969, and then it was introduced into cardiovascular surgery, general surgery, Urology, fetal surgery, plastic surgery and so on, and was more and more widely used in clinical.
Lixiulong nose material mainly adopts reinforced and shaped expansion, which is natural and lifelike after implantation. After the vascular tissue grows into, the expanded material is used. Rapid integration with human tissue, no reflection, no activity, light weight, no sense of falling. E-PTFE has been used in clinic for nearly 30 years, and no carcinogenesis has been reported.
立秀Tisuthes—中高端整形假体
立秀品牌诞生于中国,自研发上市至今已有近二十年历史。是已通过欧盟CE认证、韩国KFDA认证、 泰国DFTA认证的专业整形材料。
逾500,000临床案例,持续跟踪无不良反馈。畅销全球二十多个国家和地区,蜚声中外,与上海九院及北大第三附属医院建立长期战略合作关系。目前在中国隆鼻市场中占有率达到70%。
Lixiu brand was born in China, and has a history of nearly 20 years since its R & D and listing. It is a professional plastic material which has passed the CE certification of EU, KFDA certification of Korea and DFTA certification of Thailand.
More than 500000 clinical cases were followed up continuously without adverse feedback. It is well-known both at home and abroad and has established long-term strategic cooperation with Shanghai Ninth Hospital and the Third Affiliated Hospital of Peking University. At present, it occupies 70% of the rhinoplasty market in China.
更适合亚洲人的整形材料
一次植入,终身美丽;造型多样,易于雕刻塑形;适合对鼻型精致度要求更高的客户;与细胞融合,浑然一体;适合追求自然,健康效果的客户。
Once implanted, life-long beauty; various shapes, easy to carve and shape; suitable for customers with higher requirements for nose type refinement; integrated with cells; suitable for customers who pursue natural and healthy effects.
立秀发展前景
美国JCI认证,被公认为是评价医院水平的“金标准”。截至2017年2月底,中国大陆通过JCI认证的医院不过73家。泰国,有42家医院和诊所获得JCI认证,位居东盟国家第一。泰国医疗的传统强项是整形美容、变性手术、健康体检、牙齿美容。近年来在心脏疾病、试管婴儿、慢性肾脏疾病、糖尿病、肿瘤等领域也颇有建树,水平比肩欧美发达国家。
根据《无国界病人》杂志报道,泰国已成为全球医疗旅游的首要目的地,医疗旅游规模位居世界第一。
JCI certification is recognized as the "gold standard" to evaluate the level of hospitals. As of the end of February 2017, Chinese mainland approved 73 hospitals in JCI. Thailand, with 42 hospitals and clinics certified by JCI, ranks first in ASEAN countries. The traditional strengths of Thai medicine are plastic surgery, sex change surgery, physical examination and dental beauty. In recent years, it has also made great achievements in the fields of heart disease, test tube baby, chronic kidney disease, diabetes, cancer and so on, which is comparable to the developed countries in Europe and America.
According to patients without borders, Thailand has become the top destination of global medical tourism, with the largest scale of medical tourism in the world.